Page last updated: 2024-10-24

chlorambucil and Neoplasm Regression, Spontaneous

chlorambucil has been researched along with Neoplasm Regression, Spontaneous in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Neoplasm Regression, Spontaneous: Disappearance of a neoplasm or neoplastic state without the intervention of therapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Senyszyn, JJ1
Johnson, RE1
Curran, RE1
Han, T1
Sokal, JE1

Trials

1 trial available for chlorambucil and Neoplasm Regression, Spontaneous

ArticleYear
Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).
    Cancer chemotherapy reports, 1970, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Child; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Hu

1970

Other Studies

1 other study available for chlorambucil and Neoplasm Regression, Spontaneous

ArticleYear
Spontaneous remission of leukemic lymphoproliferative disease.
    Cancer, 1971, Volume: 27, Issue:3

    Topics: Adult; Aged; Chlorambucil; Female; Humans; Leukemia, Lymphoid; Leukocyte Count; Lymphocytes; Lymphom

1971